Research >

2025 Outlook

Stock Market | Economy

Omaha, NE - January 2025

The Author

Dylan Karnish, Founder & CEO

Tags >

What we think the year 2025 holds in store for the Market and Economy

​As we approach 2025, the global economy and stock market present a mixed yet intriguing landscape. Our analysis identifies key trends, challenges, and opportunities that investors should consider when positioning portfolios for the year ahead.

Economic Overview

Inflation and Federal Reserve Policy

Inflation is expected to remain a factor in 2025, though we do not anticipate a sharp acceleration. Instead, inflation will likely rise slowly from its current levels, staying above 2.5% for the year. The Federal Reserve has already acted aggressively in cutting rates, and we believe they should now adopt a more measured approach to avoid reigniting inflationary pressures. A slower pace of rate cuts would help maintain economic stability while preventing overheating.

Consumer Goods Prices

We expect prices for consumer goods to continue their upward trajectory. Corporations facing increased input costs—partly due to lingering supply chain issues and new tariffs—are likely to pass these costs on to consumers. While this could weigh on consumer sentiment, strong wage growth may mitigate the impact, keeping demand relatively stable.

Trade Policies and Tariffs

The Trump-era tariffs will remain a focal point of debate in 2025. Despite initial concerns, we believe their long-term economic impact has been less severe than predicted. These tariffs may ultimately encourage domestic production and supply chain diversification, benefiting industrials and manufacturing sectors. However, the near-term effect will likely include higher costs for imported goods, further straining consumer budgets.

Sectoral Shifts and Investment Opportunities

Inflation Beneficiaries

As inflation remains modestly above target, positioning in sectors that traditionally perform well during periods of moderate inflation is prudent. Energy and industrials are poised for gains, underpinned by strong global demand and potential fiscal spending on infrastructure projects.

  • Energy: Going into the year 2025, energy is at a very high demand. You have the clear future winners in this industry with Nuclear Energy with companies such as Cameco (CCJ) and Vistra Corp (VST). You should also expect to see good performances out of oil companies such as Exxon Mobil (XOM) and Shell Plc (SHEL) to name a few. We are expecting natural gas and coal/minerals to also outperform in 2025.​​

Finance

The financial sector—particularly M&A-focused firms—stands out as a major beneficiary in 2025. With corporations seeking growth through acquisitions, investment banks like JPMorgan Chase (JPM), KKR & Co. (KKR), and Apollo Global Management (APO) are well-positioned for a lucrative year.

Biotech and Pharmaceuticals

Biotech and pharma remain compelling opportunities despite political concerns about drug pricing reforms. Leaders like Eli Lilly (LLY) and Novo Nordisk (NVO) are expected to capitalize on their dominant positions in the diabetes and obesity markets. Additionally, emerging players like Viking Therapeutics (VKTX) and CRISPR Therapeutics (CRSP) offer significant upside potential driven by innovation and favorable clinical trial outcomes. Healthcare has been pinned down the recent years by market weariness, underperformance, and demand winding down. We saw a turn around to this case towards the end of the year with Eli Lilly (LLY) stating that their champion drug Mounjaro was in a shortage which is a good sign for the future outlook of the drug sales.  We are also seeing major innovation within the biotech and robotics industries within Health Care. With the advancement of technology, pairing of the dominant sectors ( Tech and Healthcare ), large investment and consumer demand we are seeing safe, cleared therapeutics drugs and treatments hitting the market at faster than ever speeds. Advanced robotics are also being cleared and delivered to Hospitals at fast rates, take the Da Vinci 5 from Intuitive Surgical (ISRG) success for example. They have almost a monopoly in the surgical robotics industry in hospitals due to the ease and likeness of the Da Vinci. We expect that success and market dominance to continue. 

Potential Challenges and Risks

Quantum Computing (QC)

While the promise of quantum computing remains undeniable, the industry appears prematurely hyped. Companies like IonQ (IONQ) have solid foundations, but broader market enthusiasm has inflated valuations unsustainably. Many lesser-known players lack the infrastructure and partnerships necessary for meaningful advancements, increasing the likelihood of a significant correction in 2025. Investors should adopt a cautious approach, focusing on companies with credible technological roadmaps and strategic alliances.​

Conclusion

While 2025 presents a complex investment landscape, it also offers compelling opportunities for well-informed investors. DyKa Investments recommends a diversified approach, emphasizing:

  1. Beneficial sectors: Energy, industrials, and finance.

  2. Growth-driven areas: Biotech and pharmaceuticals

  3. Cautious optimism: Avoiding speculative bubbles, particularly in quantum computing.

By aligning portfolios with these themes, investors can navigate the challenges of 2025 while capturing opportunities for growth.

Disclaimer

The information provided in this article is for informational and educational purposes only. DyKa Investments, LLC does not provide personalized investment advice, and nothing in this article constitutes financial, investment, legal, or other professional advice. Readers should not interpret this content as an endorsement of any specific investment strategy, asset, or financial instrument.

This article does not take into account the specific investment objectives, financial situation, or individual needs of any particular person. It should not be relied upon as the sole basis for making any investment decisions. Readers are encouraged to conduct their own research and consult with a licensed financial advisor before making any investment decisions.

Additionally, this material may not be reproduced, distributed, or used in any manner without the prior written consent of DyKa Investments, LLC. Unauthorized use or reproduction of this content is strictly prohibited and may be subject to legal action.

DyKa Investments, LLC expressly disclaims any and all liability in respect of actions taken or not taken based on any or all of the contents of this article.